Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.54 |
| ▸ | FABP7 | O15540 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15981181 | 0.85 | KMT2A (0.58) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL44676 | 0.85 | KMT2A (0.58) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL29381061 | 0.83 | FABP5 (0.59) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL44677 | 0.83 | FABP5 (0.59) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL29901230 | 0.83 | FABP5 (0.59) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL30667581 | 0.83 | KMT2A (0.56) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL2782675 | 0.83 | KMT2A (0.56) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL12016740 | 0.83 | KMT2A (0.56) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL9328044 | 0.82 | PPARG (0.42) | KMT2AFABP5FABP7EPHX2CA1 | |
| SCHEMBL17703893 | 0.81 | KMT2A (0.55) | KMT2AFABP5FABP7EPHX2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1419 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024120466-A1 | MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SURIO THERAPEUTICS CO., LTD (CN) | 2024-06-13 | — | — | WO | claimed |
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| US-20230391997-A1 | FLOW CELL INCLUDING A HETEROPOLYMER | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-12-07 | — | — | US | claimed |
| US-11787930-B2 | Flow cell including a heteropolymer | ILLUMINA INC. (US) | 2023-10-17 | — | — | US | claimed |
| CN-115651043-A | Preparation method of anthracycline derivative | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-115650827-A | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-114853822-A | Oligonucleotide-disulfide and synthetic method thereof | 康龙化成(宁波)科技发展有限公司 | 2022-08-05 | — | — | CN | claimed |
| EP-3911686-A1 | FLOW CELL INCLUDING A HETEROPOLYMER | Illumina, Inc. (US) | 2021-11-24 | — | — | EP | claimed |
| CN-112673034-A | Flow cell comprising heteropolymers | 伊鲁米那股份有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-108070009-B | Method for preparing DNA coding compound library and initial fragment compound and prepared DNA coding compound | 上海药明康德新药开发有限公司 | 2021-04-13 | — | — | CN | claimed |
| EP-0354522-A1 | Use of alpha-aminoboronic acid derivatives in prevention and treatement of viral diseases | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-02-14 | — | — | EP | claimed |
| US-4855286-A | HYPOTENSIVE AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | claimed |
| EP-0315574-A2 | Renin inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-10 | — | — | EP | claimed |
| EP-0310015-A2 | Renin-inhibiting dipeptides, process for their preparation, medicines containing them and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-04-05 | — | — | EP | claimed |
| EP-0255082-A2 | Renin-inhibiting di- and tripeptides, methods for their production, drugs containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-02-03 | — | — | EP | claimed |
| EP-0239874-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their application | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-10-07 | — | — | EP | claimed |
| EP-0230242-A2 | Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-07-29 | — | — | EP | claimed |
| EP-0073828-A4 | HIGH PERFORMANCE PEPTIDE SYNTHESIS. | BIORES INC (US) | 1983-11-09 | — | — | EP | claimed |
| EP-0073828-A1 | HIGH PERFORMANCE PEPTIDE SYNTHESIS | BIORESEARCH INC. (US) | 1983-03-16 | — | — | EP | claimed |
| WO-1982003077-A1 | HIGH PERFORMANCE PEPTIDE SYNTHESIS | BIORESEARCH INC (US) | 1982-09-16 | — | — | WO | claimed |